Table 3. Description of subjects assessed in studies .
Instrument | Country | Number of Subjects (% male) | Age, years (mean, range, SD (if available)) |
Type of SCI | Time since injury, years (mean, range, SD (if available)) |
I-APS | India | 42 (74) | 29.5 Range: 25-46 |
NR | 3.5 |
IMPACT-S | Netherlands | 197 (65.9) | 40.4 (18-70) | NR | 2.2 (0.9) |
WHODASII | Australia | 63 (81) | 34.7 (SD:14.6) | Paraplegia (21) Tetraplegia (42) |
NR |
USER-P | Switzerland | 1549 (71.5) | 52.4 (14.8) | Paraplegia (1063) Tetraplegia (474) |
16.9 (12.7) |
IPA | Netherlands | 100 | 47.9 (14.6, Range: 23-79) |
NR | 2 years (range: 2 months-lifetime) |
PM-PAC | United States | 395 (41) | 59.9 (18.2) | NR | NR |
Abbreviations: NR, Not reported